By Nicole Ireland / The Canadian Press

  • GlitzyArmrest@lemmy.world
    link
    fedilink
    English
    arrow-up
    5
    arrow-down
    8
    ·
    1 year ago

    You are correct that it’s the drug company at fault here too, not just the public. It’s also the fault of doctors that are continuing to prescribe it off-label for weight loss.

    • AggressivelyPassive@feddit.de
      link
      fedilink
      arrow-up
      13
      arrow-down
      3
      ·
      1 year ago

      Why are the doctors at fault? There’s a drug that helps patients achieve their weight loss goals. As long as it’s prescribed to overweight people, that’s perfectly fine.

      • GlitzyArmrest@lemmy.world
        link
        fedilink
        English
        arrow-up
        8
        arrow-down
        13
        ·
        1 year ago

        Because not every doctor tells their patients the risks, including that you must continue taking it or risk gaining more weight back if you stop. It’s making more people overweight in the long run because they stop due to serious headaches (the most common side-effect).

        • AggressivelyPassive@feddit.de
          link
          fedilink
          arrow-up
          11
          arrow-down
          7
          ·
          1 year ago

          You don’t know that. That’s simply pulling “facts” out of your ass.

          It’s way too little time on the market to judge the long term effects.

        • 'M' as in 'MANCY'@lemmy.ca
          link
          fedilink
          arrow-up
          6
          arrow-down
          3
          ·
          edit-2
          1 year ago

          Most health care providers go over risks and benefits prior to initiating any kind of treatment. What the hell are you on about?

          If I have an overweight patient who has tried for years to lose weight but can’t sustain it (which is the case for most overweight people) and are at risk for metabolic diseases and cardiovascular complications, and I have something that evidence tells me can help with weight management, you bet your ass I’m going to talk about it as an option.

          Or would you prefer that fat people remain fat until they develop diabetes (and its various associated complications) before I’m even allowed to discuss semaglutide?

          Patients are oftentimes aware of the potential side effects and the rebound weight gain. People don’t jump straight to an expensive injectable drug as the first option for weight management. It’s something that they try after a string of failed attempts by other means.

          • GlitzyArmrest@lemmy.world
            link
            fedilink
            English
            arrow-up
            1
            arrow-down
            6
            ·
            1 year ago

            Most health care providers go over risks and benefits prior to initiating any kind of treatment.

            Sure, most do. I’m talking about those that do not.

            and are at risk for metabolic diseases and cardiovascular complications

            Seems pretty close the intended use in this case? Not sure this would qualify as the off-label use I’m talking about.

            Or would you prefer that fat people remain fat until they develop diabetes (and its various associated complications) before I’m even allowed to discuss semaglutide?

            When did I say that? I said nothing of the sort. I’m specifically talking about those that aren’t even overweight using it, or those without risk factors for diabetes. Because that’s happening, and it’s happening a lot.

            People don’t jump straight to an expensive injectable drug as the first option for weight management.

            This is not true for everyone. Many see Ozempic as a “magic bullet” for weight loss when that is not what it is.

    • GameGod@lemmy.ca
      link
      fedilink
      arrow-up
      6
      ·
      1 year ago

      The drug company knows exactly what it’s doing here - I came out Barbie the other day and there’s a fucking Ozempic ad besides the theatre inside the Famous Players.